2,433
Views
41
CrossRef citations to date
0
Altmetric
Review Article

Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis

, , &
Pages 339-344 | Received 20 Jul 2018, Accepted 09 Oct 2018, Published online: 11 Dec 2018

References

  • Nolan AL, Jen K. Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagnostic Pathology. 2015 May 6;10:48.
  • Impact of Drugs on Society - National Drug Threat Assessment 2010 [Internet]; 2010 updated Feb; cited 2017 Nov 25. Available from: https://www.justice.gov/archive/ndic/pubs38/38661/drugImpact.htm.
  • Gulati S, Donato A. Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis. 2012 Jul;34(1):7–10.
  • Systemic Levamisole-Induced Vasculitis in a Cocaine User without Cutaneous Findings: A Consideration in Diagnosis [Internet].: Hindawi; 2015 cited 2017 Oct 26. Available from: https://www.hindawi.com/journals/crim/2015/547023/.
  • McGrath MM, Isakova T, Rennke HG, et al. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clinical Journal of the American Society of Nephrology. 2011 Dec 1;6(12):2799–2805.
  • Pearson T, Bremmer M, Cohen J, et al. Vasculopathy related to cocaine adulterated with levamisole: A review of the literature - eScholarship. Dermatology Online Journal. 2012 July 1;18(7):1.
  • Néel A, Agard C, Hamidou M. Vasculitides induced by cocaine and/or levamisole. Joint Bone Spine. 2018 Jan;85(1):9–14.
  • Ullrich K, Koval R, Koval E, et al. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. JCR: Journal of Clinical Rheumatology. 2011 June;17(4):193–196.
  • Carlson AQ, Tuot DS, Jen K, et al. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases. Medicine. 2014 Oct;93(17):290.
  • Garg L, Gupta S, Swami A, et al. Levamisole/Cocaine induced systemic vasculitis and immune complex glomerulonephritis. Case Reports in Nephrology. 2015;2015:e372413.
  • Shiue Z, McNicholas B, Cormack F, et al. Antineutrophil cytoplasmic antibody mediated glomerulonephritis associated with levamisole-adulterated cocaine. Clinical Nephrology - Case Studies. 2015 Jan 1;3(1):37.
  • Roca-Argente L, Moll-Guillen J, Espí-Reig J, et al. Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: a case report. Annals of Translational Medicine. 2015 Oct 30;3(18):271.
  • Chawdhary K, Parke A. Connecticut medicine. Connecticut Medicine. 2015 Jun-Jul;79(6):343–346.
  • Liu YJ, Mutnuri S, Siddiqui SB, et al. Levamisole-adulterated cocaine nephrotoxicity ultrastructural features. Am J Clin Pathol. 2016 May 1;145(5):720–726.
  • Veronese FV, Dode RSO, Friderichs M, et al. Cocaine/levamisole-induced systemic vasculitis with retiform purpura and pauci-immune glomerulonephritis. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E biológicas/Sociedade Brasileira De Biofísica … [Et Al.]. 2016;49(5):e5244.
  • Moinuddin I, Madhrira M, Bracamonte E, et al. Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathology - Research and Practice. 2016 July 1;212(7):650–653.
  • van der Veer T, Pennings E, Tervaert JWC, et al. Levamisole-contaminated cocaine: a hairy affair. BMJ Case Reports. 2015 Aug 26;2015:bcr2015210970.
  • Sirvent AE, Enríquez R, Andrada E, et al. Glomerulonefritis necrosante en el síndrome por consumo de cocaína y levamisol. Nefrología. 2016 January 1,;36(1):76–78.
  • Carrara C, Emili S, Lin M, et al. Necrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaine. Clin Kidney J. 2016 Apr;9:234–238.
  • Collister D, Sathianathan C, Ryz K, et al. ANCA associated vasculitis secondary to levamisole-adultered cocaine with associated membranous nephropathy: a case series. American Journal of Nephrology. 2017;45(3):209–216.
  • Olives TD, Kornas RL, Fujisawa R, et al. Unexpected complication of cocaine-associated anti-neutrophil cytoplasmic antibody vasculitis related to persistent in-hospital cocaine use. Journal of Addiction Medicine. 2017 Apr 1;11(2):157–160.
  • English JCI. Granulomatous disorders of adult skin, an issue of dermatologic clinics. Philadelphia (PA): Elsevier Health Sciences; 2015.
  • Al-Hussain T, Hussein MH, Conca W, et al. Pathophysiology of ANCA-associated vasculitis. Advances in Anatomic Pathology. 2017 July;24(4):226.
  • Sangaletti S, Tripodo C, Chiodoni C, et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood. 2012 Oct 11,;120(15):3007–3018.
  • Kessenbrock K, Krumbholz M, Schonermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nature Medicine. 2009 Jun;15(6):623–625.
  • Abreu-Velez AM, Smith JG, Howard MS. Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides. N Am J Med Sci. 2009 Nov;1(6):309–313.
  • Wang H, Sha L, Ma T, et al. Circulating level of neutrophil extracellular traps is not a useful biomarker for assessing disease activity in antineutrophil cytoplasmic antibody-associated vasculitis: e0148197. PLoS ONE. 2016 Feb 1;11(2):e0148197.
  • Söderberg D, Segelmark M. Neutrophil extracellular traps in ANCA-associated vasculitis. Frontiers in Immunology. 2016;7(UNSP 256):256.
  • Rao AN, Kazzaz NM, Knight JS. Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? 世界心脏病学杂志: 英文版(电子版). 2015;7(12):829–842.
  • Kambas K, Chrysanthopoulou A, Vassilopoulos D, et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Annals of the Rheumatic Diseases. 2014 Oct 19,;73(10):1854–1863.
  • Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nature Medicine. 2017 Mar 1,;23(3):279–287.
  • Söderberg D, Segelmark M. Neutrophil extracellular traps in vasculitis, friend or foe? Current Opinion in Rheumatology. 2018 Jan;30(1):16–23.
  • Lood C, Hughes GC. Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatology (Oxford). 2017 Apr 1;56(4):638–643.
  • Carmona-Rivera C, Purmalek MM, Moore E, et al. A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity. JCI Insight. 2017;2(3):e89780.
  • Nakazawa D, Tomaru U, Suzuki A, et al. Abnormal conformation and impaired degradation of propylthiouracil‐induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis & Rheumatism. 2012 Nov;64(11):3779–3787.